On 23 May, the “Invest in Shanghai, Sharethe Future” Overseas Promotion Campaign (New York, U.S.) was successfully heldin New York. Shanghai Mayor Gong Zheng delivered a keynote speech at thepromotion event, said, “Shanghai is speeding up the process of building itselfinto an international center of economy, finance, trade, shipping, andtechnologica

Shanghai, China & JERSEYCITY, N.J. – May 24, 2024 – Shanghai Henlius Biotech, Inc. (2696.HK) andOrganon (NYSE: OGN) today announced that the European Medicines Agency (EMA)has validated the marketing authorization applications (MAAs) for HLX14, aninvestigational Prolia^®and Xgeva^®(denosumab)biosimilar. Denosumab has been approved in various countries and regi

The 4th BEYOND International Technology Innovation Expo (BEYOND Expo 2024) commenced with a spectacular opening ceremony on 22 May at the Venetian Theatre in the Venetian Macao. At the opening ceremony, Guo Guangchang, Chairman of Fosun International, said that Fosun will steadfastly take innovation and globalization as the core drivers for its development in the next 30 ye

On 22 May 2024, Guo Guangchang, Chairman of Fosun International and his delegation met Ho Iat Seng, Chief Executive of Macao Special Administrative Region of the PRC (Macao SAR). Guo Guangchang provided an update on Fosun's business development in Macao SAR. Li Haifeng, Chairman of Fosun Foundation, Wen Xiaodong, Chairman of Fosun Infrastructure G

Shanghai, China, May22,2024 – Shanghai Henlius Biotech, Inc. (2696.HK) announced that the supplementalnew drug applications of its independently developed adalimumab biosimilarHANDAYUAN for the four new indications of polyarticular juvenile idiopathicarthritis, pediatric plaque psoriasis, Crohn’s disease and pediatric Crohn’sdisease have been approved by t

On 14 May, Fosun Health and Foshan Chancheng District Chanxi New City Investment and Construction Co., Ltd. (hereinafter referred to as "Foshan Chanxi City Investment") entered into a "Capital Increase and Share Expansion Agreement". According to the agreement, Foshan Chanxi City Investment proposed to designate entities (including funds,

On 15 May, a massive scroll unfurled in the central square of Yuyuan Garden in Shanghai. Close to a hundred families collectively painted the "Fosun lifestyle" scroll, illuminating the "star of Fosun". At the same time, thousands of families painted the "Fosun lifestyle" scroll in 20 commercial districts and communities such as Shanghe Yinxiang in Ru

On 13 May 2024, Fortune China magazine released the 2024 China ESG Impact List, and Fosun International Limited (“Fosun International”or the “Company”) (HKEX stock code: 00656) was included in the list, highlighting its outstanding performance and industry leadership in the areas of environmental, social and governance (ESG).FortuneChinapointed out